Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan
· Delayed Price · Currency is JPY 2,200.00
+7.00 (0.32%)
Mar 10, 2026, 3:30 PM JST
Zeria Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 94,473 | 99,488 | 93,978 | 98,960 | 85,331 | 96,124 | Upgrade
|
| Market Cap Growth | 3.34% | 5.86% | -5.03% | 15.97% | -11.23% | -0.78% | Upgrade
|
| Enterprise Value | 111,380 | 119,281 | 125,376 | 134,397 | 126,409 | 124,464 | Upgrade
|
| Last Close Price | 2193.00 | 2231.24 | 2064.91 | 2131.85 | 1774.45 | 1926.45 | Upgrade
|
| PE Ratio | 13.31 | 10.01 | 12.16 | 15.97 | 21.54 | 30.82 | Upgrade
|
| Forward PE | 10.39 | 10.13 | 11.34 | 12.53 | 20.60 | 28.59 | Upgrade
|
| PS Ratio | 1.09 | 1.14 | 1.24 | 1.45 | 1.43 | 1.73 | Upgrade
|
| PB Ratio | 0.98 | 1.11 | 1.18 | 1.51 | 1.55 | 1.71 | Upgrade
|
| P/TBV Ratio | 1.65 | 2.02 | 2.58 | 4.21 | 6.23 | 6.90 | Upgrade
|
| P/FCF Ratio | - | 8.66 | 10.12 | 9.20 | 10.82 | 15.60 | Upgrade
|
| P/OCF Ratio | - | 7.70 | 7.71 | 7.52 | 9.53 | 13.94 | Upgrade
|
| EV/Sales Ratio | 1.29 | 1.37 | 1.66 | 1.97 | 2.12 | 2.25 | Upgrade
|
| EV/EBITDA Ratio | 6.26 | 6.04 | 7.30 | 8.86 | 10.74 | 15.80 | Upgrade
|
| EV/EBIT Ratio | 10.87 | 9.78 | 13.03 | 14.91 | 19.86 | 36.15 | Upgrade
|
| EV/FCF Ratio | - | 10.38 | 13.51 | 12.49 | 16.03 | 20.20 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.46 | 0.58 | 0.75 | 0.95 | 0.89 | Upgrade
|
| Debt / EBITDA Ratio | - | 2.08 | 2.69 | 3.26 | 4.44 | 6.34 | Upgrade
|
| Debt / FCF Ratio | - | 3.58 | 4.98 | 4.60 | 6.62 | 8.11 | Upgrade
|
| Net Debt / Equity Ratio | 0.17 | 0.20 | 0.32 | 0.51 | 0.74 | 0.72 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.93 | 0.89 | 1.51 | 2.19 | 3.44 | 5.10 | Upgrade
|
| Net Debt / FCF Ratio | - | 1.53 | 2.79 | 3.09 | 5.14 | 6.52 | Upgrade
|
| Asset Turnover | 0.54 | 0.56 | 0.53 | 0.53 | 0.48 | 0.49 | Upgrade
|
| Inventory Turnover | 1.27 | 1.51 | 1.48 | 1.53 | 1.51 | 1.53 | Upgrade
|
| Quick Ratio | 0.92 | 0.92 | 0.76 | 0.71 | 0.63 | 0.43 | Upgrade
|
| Current Ratio | 1.33 | 1.28 | 1.06 | 1.02 | 0.94 | 0.69 | Upgrade
|
| Return on Equity (ROE) | 7.99% | 11.75% | 10.58% | 10.28% | 7.14% | 5.75% | Upgrade
|
| Return on Assets (ROA) | 4.07% | 4.92% | 4.21% | 4.35% | 3.23% | 1.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.48% | 9.04% | 7.61% | 7.91% | 4.61% | 3.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 11.60% | 10.00% | 10.30% | 7.90% | 5.10% | Upgrade
|
| Earnings Yield | 7.69% | 9.99% | 8.23% | 6.26% | 4.64% | 3.25% | Upgrade
|
| FCF Yield | - | 11.55% | 9.88% | 10.87% | 9.24% | 6.41% | Upgrade
|
| Dividend Yield | 2.17% | 2.11% | 2.13% | 1.88% | 1.97% | 1.76% | Upgrade
|
| Payout Ratio | - | 19.89% | 25.03% | 25.67% | 38.83% | 50.27% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.00% | 0.21% | 2.14% | 2.02% | 1.38% | Upgrade
|
| Total Shareholder Return | 2.17% | 2.11% | 2.34% | 4.01% | 4.00% | 3.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.